PLA2G4B Antikörper (N-Term)

Produktnummer ABIN927721

Produktdetails anti-PLA2G4B Antikörper

Target: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Bindungsspezifität: N-Term

Reaktivität: Human, Maus, Ratte, Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLA2G4B Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Kreuzreaktivität: Maus, Ratte (Rattus), Rind (Kuh)

Aufreinigung: Purified

Immunogen: PLA2 G2 antibody was raised in rabbit using the N terminal of PLA2 2 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

PLA2G4B Blocking Peptide, catalog no. 33R-1112, is also available for use as a blocking control in assays to test for specificity of this PLA2G4B antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu PLA2G4B

Target: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Andere Bezeichnung: PLA2G4B (PLA2G4B Produkte)

Synonyme: HsT16992 antikoerper, cPLA2-beta antikoerper, A030011C02Rik antikoerper, Gm1013 antikoerper, phospholipase A2 group IVB antikoerper, phospholipase A2, group IVB (cytosolic) antikoerper, PLA2G4B antikoerper, Pla2g4b antikoerper

Hintergrund: PLA2G4B gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Synonyms: Polyclonal PLA2G4B antibody, Anti-PLA2G4B antibody, phospholipase A2, group IVB, cytosolic antibody, FLJ42498 antibody, HsT16992 antibody, cPLA2-beta antibody.

Pathways: ER-Nucleus Signaling, VEGF Signaling